SENORES PHARMACEUTICALS
Back to Balance Sheet
|
SENORES PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-19 Cr | ₹-15 Cr | ₹2.10 Cr | ₹-0.45 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SENORES PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-19 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹2.10 Cr |
| Mar2022 | ₹-0.45 Cr |
How is Deferred Tax Assets / Liabilities of SENORES PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-19 Cr | Negative | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹2.10 Cr | Positive | |
| Mar2022 | ₹-0.45 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹6,158.3 Cr | 5.3% | 28.9% | 130.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | 5.3% |
28.9% |
130.3% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses